{"id":36148,"date":"2018-05-21T08:30:05","date_gmt":"2018-05-21T06:30:05","guid":{"rendered":"https:\/\/cms.stage.munich-startup.gmbh\/?p=36148"},"modified":"2018-05-18T11:11:03","modified_gmt":"2018-05-18T09:11:03","slug":"advancecor-erhaelt-6-millionen-euro","status":"publish","type":"post","link":"https:\/\/cms.stage.munich-startup.gmbh\/en\/36148\/advancecor-erhaelt-6-millionen-euro\/","title":{"rendered":"BioTech-Unternehmen advanceCOR erh\u00e4lt 6 Millionen Euro"},"content":{"rendered":"<div class=\"entry-content\"><p><strong>Die advanceCOR GmbH mit Sitz in Martinsried hat eine Finanzierungrunde in H\u00f6he von sechs Millionen Euro\u00a0 \u00a0erfolgreich abgeschlossen. Investiert haben\u00a0 die MIG Fonds als Konsortialf\u00fchrer zusammen mit den Co-Investoren First Capital Partner, Occident Group, Bayern Kapital, High-Tech Gr\u00fcnderfonds und KfW Bank.<\/strong><\/p>\n<p>Die Biotech-Firma entwickelt personalisierte Therapien f\u00fcr Herz-Kreislauf-Erkrankungen. Im Zentrum der Aktivit\u00e4ten von\u00a0 \u00a0<a href=\"https:\/\/advancecor.de\/\" target=\"_blank\" rel=\"noopener\">advanceCOR<\/a> steht die vielversprechende Substanz Revacept.\u00a0\u00a0 Es wird der Ansatz verfolgt, biotechnologische Therapieprinzipien unter Einbindung einer begleitenden Diagnostik zu einer zielgerichteten und nebenwirkungsarmen Therapie zu kombinieren.<\/p>\n<h3>Zwei Studien sollen Proof of Concept liefern<\/h3>\n<p><strong>Matthias Guth<\/strong>, Venture Partner der\u00a0 MIG Verwaltungs AG (MIG AG), sagt:<\/p>\n<blockquote><p>&#8222;Mit dieser Finanzierung wird advanceCOR die bereits begonnene Phase II Patienten-Studie mit Revacept an Patienten mit symptomatischer Karotisstenose (<em>Anm. d. Red.:<\/em> Verengung der Halsschlagader) und Schlaganfall abschlie\u00dfen.&#8220;<\/p><\/blockquote>\n<p>Zus\u00e4tzlich wird eine weitere Patientenstudie mit Revacept an Patienten mit koronarer Herzerkrankung und Katheterintervention zusammen mit dem Deutschen Zentrum f\u00fcr Herz-Kreislaufforschung (DZHK) durchgef\u00fchrt. Es wurden bereits zahlreiche Patienten in die Studie eingeschlossen. Bei der Phase II Studie an Patienten mit symptomatischer Karotisstenose steht die Rekrutierungsphase mit den geplanten 150 Patienten kurz vor dem Abschluss.<\/p>\n<p><strong>Michael Motschmann<\/strong>, General Partner und Vorstand der MIG AG, erl\u00e4utert:<\/p>\n<blockquote><p>&#8222;Mit den Ergebnissen dieser beiden klinischen Studien wird advanceCOR im Erfolgsfall ein proof-of-concept erzielen. Es zeichnet sich dann ein Verkauf oder die gemeinsame weitere Entwicklung mit einem gro\u00dfen Pharmapartner ab.&#8220;<\/p><\/blockquote>\n<p>Revacept\u00a0 \u00a0wird in Fachkreisen als bemerkenswert nebenwirkungsarm bezeichnet.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Die advanceCOR GmbH mit Sitz in Martinsried hat eine Finanzierungrunde in H\u00f6he von sechs Millionen Euro\u00a0 \u00a0erfolgreich abgeschlossen. Investiert haben\u00a0 die MIG Fonds als Konsortialf\u00fchrer zusammen mit den Co-Investoren First Capital Partner, Occident Group, Bayern Kapital, High-Tech Gr\u00fcnderfonds und KfW Bank. Die Biotech-Firma entwickelt personalisierte Therapien f\u00fcr Herz-Kreislauf-Erkrankungen. Im Zentrum &hellip;<\/p>","protected":false},"author":3,"featured_media":36353,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5129,1],"tags":[3162,371,52,156],"class_list":["post-36148","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-deals","category-news","tag-advancecor","tag-biotech","tag-finanzierung","tag-life-science"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>BioTech-Unternehmen advanceCOR erh\u00e4lt 6 Millionen Euro - Munich Startup<\/title>\n<meta name=\"description\" content=\"Die advanceCOR GmbH mit Sitz in Martinsried hat eine Finanzierungrunde in H\u00f6he von sechs Millionen Euro\u00a0erfolgreich abgeschlossen.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.stage.munich-startup.gmbh\/en\/36148\/advancecor-erhaelt-6-millionen-euro\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioTech-Unternehmen advanceCOR erh\u00e4lt 6 Millionen Euro - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Die advanceCOR GmbH mit Sitz in Martinsried hat eine Finanzierungrunde in H\u00f6he von sechs Millionen Euro\u00a0erfolgreich abgeschlossen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.stage.munich-startup.gmbh\/en\/36148\/advancecor-erhaelt-6-millionen-euro\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/profile.php?id=100009572160192\" \/>\n<meta property=\"article:published_time\" content=\"2018-05-21T06:30:05+00:00\" \/>\n<meta name=\"author\" content=\"Florian Deglmann\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@FlorianDeglmann\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Florian Deglmann\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/36148\/advancecor-erhaelt-6-millionen-euro\/\",\"url\":\"https:\/\/cms.stage.munich-startup.gmbh\/36148\/advancecor-erhaelt-6-millionen-euro\/\",\"name\":\"BioTech-Unternehmen advanceCOR erh\u00e4lt 6 Millionen Euro - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/36148\/advancecor-erhaelt-6-millionen-euro\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/36148\/advancecor-erhaelt-6-millionen-euro\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.stage.munich-startup.gmbh\/wp-content\/uploads\/2018\/05\/ecg-2270728_1280.jpg\",\"datePublished\":\"2018-05-21T06:30:05+00:00\",\"author\":{\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/#\/schema\/person\/e9a923eaacd019b5199171badd1b772f\"},\"description\":\"Die advanceCOR GmbH mit Sitz in Martinsried hat eine Finanzierungrunde in H\u00f6he von sechs Millionen Euro\u00a0erfolgreich abgeschlossen.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/36148\/advancecor-erhaelt-6-millionen-euro\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.stage.munich-startup.gmbh\/36148\/advancecor-erhaelt-6-millionen-euro\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/36148\/advancecor-erhaelt-6-millionen-euro\/#primaryimage\",\"url\":\"https:\/\/cms.stage.munich-startup.gmbh\/wp-content\/uploads\/2018\/05\/ecg-2270728_1280.jpg\",\"contentUrl\":\"https:\/\/cms.stage.munich-startup.gmbh\/wp-content\/uploads\/2018\/05\/ecg-2270728_1280.jpg\",\"width\":1280,\"height\":853,\"caption\":\"AdvanceCor\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/36148\/advancecor-erhaelt-6-millionen-euro\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/cms.stage.munich-startup.gmbh\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioTech-Unternehmen advanceCOR erh\u00e4lt 6 Millionen Euro\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/#website\",\"url\":\"https:\/\/cms.stage.munich-startup.gmbh\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.stage.munich-startup.gmbh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/#\/schema\/person\/e9a923eaacd019b5199171badd1b772f\",\"name\":\"Florian Deglmann\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5a16a770a1cdb8f59f019287b53f6cf22c062c757827d59d6ebda81fdb697b61?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5a16a770a1cdb8f59f019287b53f6cf22c062c757827d59d6ebda81fdb697b61?s=96&d=mm&r=g\",\"caption\":\"Florian Deglmann\"},\"description\":\"Der Exil-N\u00fcrnberger erforschte bis April 2019 als Redakteur die M\u00fcnchner Startup-Szene.\",\"sameAs\":[\"http:\/\/cms.stage.munich-startup.gmbh\",\"https:\/\/www.facebook.com\/profile.php?id=100009572160192\",\"https:\/\/x.com\/FlorianDeglmann\"],\"url\":\"https:\/\/cms.stage.munich-startup.gmbh\/en\/author\/deglmann\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-content\/uploads\/2018\/05\/ecg-2270728_1280.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioTech-Unternehmen advanceCOR erh\u00e4lt 6 Millionen Euro - Munich Startup","description":"Die advanceCOR GmbH mit Sitz in Martinsried hat eine Finanzierungrunde in H\u00f6he von sechs Millionen Euro\u00a0erfolgreich abgeschlossen.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.stage.munich-startup.gmbh\/en\/36148\/advancecor-erhaelt-6-millionen-euro\/","og_locale":"en_US","og_type":"article","og_title":"BioTech-Unternehmen advanceCOR erh\u00e4lt 6 Millionen Euro - Munich Startup","og_description":"Die advanceCOR GmbH mit Sitz in Martinsried hat eine Finanzierungrunde in H\u00f6he von sechs Millionen Euro\u00a0erfolgreich abgeschlossen.","og_url":"https:\/\/cms.stage.munich-startup.gmbh\/en\/36148\/advancecor-erhaelt-6-millionen-euro\/","og_site_name":"Munich Startup","article_author":"https:\/\/www.facebook.com\/profile.php?id=100009572160192","article_published_time":"2018-05-21T06:30:05+00:00","author":"Florian Deglmann","twitter_card":"summary_large_image","twitter_creator":"@FlorianDeglmann","twitter_misc":{"Written by":"Florian Deglmann","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.stage.munich-startup.gmbh\/36148\/advancecor-erhaelt-6-millionen-euro\/","url":"https:\/\/cms.stage.munich-startup.gmbh\/36148\/advancecor-erhaelt-6-millionen-euro\/","name":"BioTech-Unternehmen advanceCOR erh\u00e4lt 6 Millionen Euro - Munich Startup","isPartOf":{"@id":"https:\/\/cms.stage.munich-startup.gmbh\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.stage.munich-startup.gmbh\/36148\/advancecor-erhaelt-6-millionen-euro\/#primaryimage"},"image":{"@id":"https:\/\/cms.stage.munich-startup.gmbh\/36148\/advancecor-erhaelt-6-millionen-euro\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.stage.munich-startup.gmbh\/wp-content\/uploads\/2018\/05\/ecg-2270728_1280.jpg","datePublished":"2018-05-21T06:30:05+00:00","author":{"@id":"https:\/\/cms.stage.munich-startup.gmbh\/#\/schema\/person\/e9a923eaacd019b5199171badd1b772f"},"description":"Die advanceCOR GmbH mit Sitz in Martinsried hat eine Finanzierungrunde in H\u00f6he von sechs Millionen Euro\u00a0erfolgreich abgeschlossen.","breadcrumb":{"@id":"https:\/\/cms.stage.munich-startup.gmbh\/36148\/advancecor-erhaelt-6-millionen-euro\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.stage.munich-startup.gmbh\/36148\/advancecor-erhaelt-6-millionen-euro\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.stage.munich-startup.gmbh\/36148\/advancecor-erhaelt-6-millionen-euro\/#primaryimage","url":"https:\/\/cms.stage.munich-startup.gmbh\/wp-content\/uploads\/2018\/05\/ecg-2270728_1280.jpg","contentUrl":"https:\/\/cms.stage.munich-startup.gmbh\/wp-content\/uploads\/2018\/05\/ecg-2270728_1280.jpg","width":1280,"height":853,"caption":"AdvanceCor"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.stage.munich-startup.gmbh\/36148\/advancecor-erhaelt-6-millionen-euro\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/cms.stage.munich-startup.gmbh\/"},{"@type":"ListItem","position":2,"name":"BioTech-Unternehmen advanceCOR erh\u00e4lt 6 Millionen Euro"}]},{"@type":"WebSite","@id":"https:\/\/cms.stage.munich-startup.gmbh\/#website","url":"https:\/\/cms.stage.munich-startup.gmbh\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.stage.munich-startup.gmbh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.stage.munich-startup.gmbh\/#\/schema\/person\/e9a923eaacd019b5199171badd1b772f","name":"Florian Deglmann","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.stage.munich-startup.gmbh\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5a16a770a1cdb8f59f019287b53f6cf22c062c757827d59d6ebda81fdb697b61?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5a16a770a1cdb8f59f019287b53f6cf22c062c757827d59d6ebda81fdb697b61?s=96&d=mm&r=g","caption":"Florian Deglmann"},"description":"Der Exil-N\u00fcrnberger erforschte bis April 2019 als Redakteur die M\u00fcnchner Startup-Szene.","sameAs":["http:\/\/cms.stage.munich-startup.gmbh","https:\/\/www.facebook.com\/profile.php?id=100009572160192","https:\/\/x.com\/FlorianDeglmann"],"url":"https:\/\/cms.stage.munich-startup.gmbh\/en\/author\/deglmann\/"}]},"og_image":[{"width":1280,"height":853,"url":"https:\/\/cms.stage.munich-startup.gmbh\/wp-content\/uploads\/2018\/05\/ecg-2270728_1280.jpg","type":"image\/jpeg"}]},"_links":{"self":[{"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/posts\/36148","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/comments?post=36148"}],"version-history":[{"count":0,"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/posts\/36148\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/media\/36353"}],"wp:attachment":[{"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/media?parent=36148"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/categories?post=36148"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/tags?post=36148"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}